Drug intelligence / Profile preview

polygeline

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intravenous
01

Overview

Polygeline is a gelatin-based colloid solution used as a plasma volume expander for the treatment of hypovolemia—a condition characterized by decreased circulating blood volume. It is commonly administered intravenously in clinical settings such as surgery, trauma, burns, and shock to rapidly restore blood volume and improve hemodynamic stability[1][3][5]. Polygeline is a polymer of urea and degraded gelatin-derived polypeptides with an average molecular weight around 30,000–35,000 Daltons[6][7]. Its mechanism of action involves increasing oncotic pressure in the bloodstream to draw fluid into the vascular compartment. The drug has a short half-life (3–6 hours), which may be prolonged in patients with renal impairment[6]. It is marketed under brand names such as Haemaccel and used for indications including hypovolemic shock due to hemorrhage or burns, plasma exchange procedures, extracorporeal circulation support during surgery, isolated organ perfusion procedures, and as a carrier solution for insulin administration[3][7].

Brand names
Haemaccel
Other names
poligelinapolygelinumheamaccelpolygelines

Beyond the preview

Go deeper on polygeline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polygeline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call